Validation of the ANCA renal risk score in a London cohort: potential impact of treatment on prediction outcome

A risk score using 3 clinicopathologic parameters was developed by Brix et  al.1 to predict renal survival at 36 months in patients with newly diagnosed antineutrophil cytoplasm antibody–associated glomerulonephritis.1 Smith et al. validated the tool in 102 Scottish patients.2

Source: Kidney International - January 26, 2021 Category: Urology & Nephrology Authors: Pek Ghe Tan, Jennifer O ’Brien, Charles D. Pusey, Stephen P. McAdoo Tags: Letter to the Editor Source Type: research